Ribonucleotide reductase inhibitors as anti-herpes agents
- PMID: 16621038
- DOI: 10.1016/j.antiviral.2006.03.002
Ribonucleotide reductase inhibitors as anti-herpes agents
Abstract
Ribonucleotide reductases (RNRs) supply the 2'-deoxyribonucleotide building blocks for DNA synthesis in mammalian cells and for herpes viruses. The viral-encoded RNRs have unique protein sequences that differ from mammalian enzyme primary structures. Selective inhibition of a viral RNR might provide an approach to new anti-herpes agents with minimal effects on the mammalian host RNRs. This review summarizes efforts to develop anti-herpes agents that selectively target viral-encoded RNRs.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
